Diagnosis and treatment of a patient with pulmonary infection caused by Emergomyces Orientalis: a case report

References

• Schwartz IS, Govender NP, Sigler L, et al. Emergomyces: the global rise of new dimorphic fungal pathogens. PLoS Pathog. 2019;15(9):e1007977. doi:10.1371/journal.ppat.1007977
   PubMed Web of Science ®Google Scholar
• Rooms I, Mugisha P, Gambichler T, et al. Disseminated emergomycosis in a person with HIV infection, Uganda. Emerg Infect Dis. 2019;25(9):1750–1751. doi:10.3201/eid2509.181234
   PubMed Web of Science ®Google Scholar
• Kenyon C, Bonorchis K, Corcoran C, et al. A dimorphic fungus causing disseminated infection in South Africa. N Engl J Med. 2013;369(15):1416–1424. doi:10.1056/NEJMoa1215460
   PubMed Web of Science ®Google Scholar
• Anstead GM, Sutton DA, Graybill JR. Adiaspiromycosis causing respiratory failure and a review of human infections due to Emmonsia and Chrysosporium spp. J Clin Microbiol. 2012;50(4):1346–1354. doi:10.1128/JCM.00226-11
   PubMed Web of Science ®Google Scholar
• van Hougenhouck-Tulleken WG, Papavarnavas NS, Nel JS, et al. HIV-associated disseminated emmonsiosis, Johannesburg, South Africa. Emerg Infect Dis. 2014;20(12):2164–2166. doi:10.3201/eid2012.140902
   PubMed Web of Science ®Google Scholar
• Heys I, Taljaard J, Orth H. An emmonsia species causing disseminated infection in South Africa. N Engl J Med. 2014;370(3):283–284. doi:10.1056/NEJMc1314277
   PubMed Web of Science ®Google Scholar
• Tang XH, Zhou H, Zhang XQ, Han JD, Gao Q. Cutaneous disseminated emmonsiosis due to Emmonsia pasteuriana in apatient with cytomegalovirus enteritis. JAMA Dermatol. 2015;151(11):1263–1264. doi:10.1001/jamadermatol.2015.1792
   PubMed Web of Science ®Google Scholar
• Wang P, Kenyon C, de Hoog S, et al. A novel dimorphic pathogen, Emergomyces orientalis (Onygenales), agent of disseminated infection. Mycoses. 2017;60(5):310–319. doi:10.1111/myc.12583
   PubMed Web of Science ®Google Scholar
• Gast KB, van der Hoeven A, de Boer MGJ, et al. Two cases of Emergomyces pasteurianus infection in immunocompromised patients in the Netherlands. Med Mycol Case Rep. 2019;24:5–8. doi:10.1016/j.mmcr.2019.01.005
   PubMed Web of Science ®Google Scholar
• Malik R, Capoor MR, Vanidassane I, et al. Disseminated Emmonsia pasteuriana infection in India: a case report and areview. Mycoses. 2016;59(2):127–132. doi:10.1111/myc.12437
   PubMed Web of Science ®Google Scholar
• Capoor MR, Mishra N, Kolte S, et al. Disseminated Emergomyces pasteurianus infection in India: a case report and a review. Mycopathologia. 2020;185(1):193–200. doi:10.1007/s11046-019-00387-y
   PubMed Web of Science ®Google Scholar
• Samaddar A, Sharma A. Emergomycosis, an emerging systemic mycosis in immunocompromised patients: current trends and future prospects. Front Med (Lausanne). 2021;8:670731. doi:10.3389/fmed.2021.670731
   PubMed Web of Science ®Google Scholar
• Schwartz IS, Govender NP, Corcoran C, et al. Clinical characteristics, diagnosis, management and outcomes of disseminated emmonsiosis: a retrospective case series. Clin Infect Dis. 2015;61(6):1004–1012. doi:10.1093/cid/civ439
   PubMed Web of Science ®Google Scholar
• Jiang J, Yang W, Wu Y, et al. Metagenomic next-generation sequencing for identifying pathogens in patients with rheumatic diseases and diffuse pulmonary lesions: a retrospective diagnostic study. Front Cell Infect Microbiol. 2022;12:963611. doi:10.3389/fcimb.2022.963611
   PubMed Web of Science ®Google Scholar
• Yan H, Li Z, Xia H, Li Q, Bai H. A case report on mixed pulmonary infection of nocardia nova, mycobacterium tuberculosis, and aspergillus fumigatus based on metagenomic next-generation sequencing. Front Public Health. 2022;10:927338. doi:10.3389/fpubh.2022.927338
   PubMed Web of Science ®Google Scholar
• Vinayagamoorthy K, Gangavaram DR, Skiada A, Prakash H. Emergomycosis, an emerging thermally dimorphic fungal infection: a systematic review. J Fungi (Basel). 2023;9(10):1039. doi:10.3390/jof9101039
   PubMedGoogle Scholar
• Schwartz IS, Sanche S, Wiederhold NP, Patterson TF, Sigler L. Emergomyces canadensis, a dimorphic fungus causing fatal systemic human disease in North America. Emerg Infect Dis. 2018;24(4):758–761. doi:10.3201/eid2404.171765
   PubMed Web of Science ®Google Scholar
• Feng P, Yin S, Zhu G, et al. Disseminated infection caused by Emmonsia pasteuriana in a renal transplant recipient. J Dermatol. 2015;42(12):1179–1182. doi:10.1111/1346-8138.12975
   PubMed Web of Science ®Google Scholar
• Crombie K, Spengane Z, Locketz M, et al. Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy. PLoS Negl Trop Dis. 2018;12(3):e0006173. doi:10.1371/journal.pntd.0006173
   PubMed Web of Science ®Google Scholar
• Capoor MR, Mishra N, Kolte SG, et al. Disseminated Emergomyces pasteurianus Infection in India: a case report and a review. Mycopathologia. 2020;185(1):193–200. doi:10.1007/s11046-019-00387-y
   PubMed Web of Science ®Google Scholar
• Chik KK, To WK. Autochthonous Emergomyces pasteurianus pneumonia in an immunocompromised patient in Hong Kong: a case report. Hong Kong Med J. 2020;26(5):446–448. doi:10.12809/hkmj198280
   PubMed Web of Science ®Google Scholar
• He D, Quan M, Zhong H, et al. Emergomyces orientalis emergomycosis diagnosed by metagenomic next-generation sequencing. Emerg Infect Dis. 2021;27(10):2740–2742. doi:10.3201/eid2710.210769
   PubMed Web of Science ®Google Scholar
• Mah J, Bakker A, Tseng C, et al. Isolated pulmonary emergomycosis in an immunocompetent patient in Alberta, Canada. Open Forum Infect Dis. 2022;9(3):ofac021. doi:10.1093/ofid/ofac021
   PubMed Web of Science ®Google Scholar
• Dukik K, Al-Hatmi AMS, Curfs-Breuker I, Faro D, de Hoog S, Meis JF. Antifungal susceptibility of emerging dimorphic pathogens in the family Ajellomycetaceae. Antimicrob. Agents Chemother. 2017;62(1):e01886–17. doi:10.1128/AAC.01886-17
   PubMed Web of Science ®Google Scholar
• Maphanga TG, Britz E, Zulu TG, Mpembe RS, Naicker SD, Schwartz IS. In vitro antifungal susceptibility of yeast and mold phases of isolates of dimorphic fungal pathogen Emergomyces africanus (formerly Emmonsia sp.) from HIV-infected South African patients. J Clin Microbiol. 2017;55(6):1812–1820. doi:10.1128/JCM.02524-16
   PubMed Web of Science ®Google Scholar
• Youngs J, Low JM, Whitney L, et al. Safety and efficacy of intermittent high-dose liposomal amphotericin B antifungal prophylaxis in haemato-oncology: an eight-year single-centre experience and review of the literature. J Fungi (Basel). 2020;6(4):385. doi:10.3390/jof6040385
   PubMedGoogle Scholar